Gaurav Shah
CEO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Rocket Pharmaceuticals, Inc. (RCKT) | Chief Executive Officer | $671,076 | $3,510,241 |
| 2024 | Rocket Pharmaceuticals, Inc. (RCKT) | Chief Executive Officer | $635,880 | $6,841,407 |
| 2023 | Rocket Pharmaceuticals, Inc. (RCKT) | Chief Executive Officer | $625,000 | $8,013,553 |
| 2022 | Rocket Pharmaceuticals, Inc. (RCKT) | Chief Executive Officer | $598,333 | $6,553,203 |
| 2021 | Rocket Pharmaceuticals, Inc. (RCKT) | Chief Executive Officer | $590,000 | $7,918,750 |
| 2020 | Rocket Pharmaceuticals, Inc. (RCKT) | Chief Executive Officer | $540,000 | $6,859,135 |
| 2019 | Rocket Pharmaceuticals, Inc. (RCKT) | Chief Executive Officer | $480,000 | $3,883,646 |
| 2018 | Rocket Pharmaceuticals, Inc. (RCKT) | M.D. Chief Executive Officer | $413,735 | $6,375,752 |
Earnings-call appearances
-
Goldman Sachs 47th Annual Global Healthcare Conference2026-06-09
Rocket Pharmaceuticals, Inc. (RCKT)
-
Jefferies Global Healthcare Conference2026-06-04
Rocket Pharmaceuticals, Inc. (RCKT)
-
KRESLADI™ FDA Approval Investor Conference Call2026-03-27
Rocket Pharmaceuticals, Inc. (RCKT)
-
Rocket Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-08-09
Rocket Pharmaceuticals, Inc. (RCKT)